HomeDevelopments

In development

Reach what other
systems miss.

We are building a delivery system to carry cannabinoids further than ordinary oral and oil formats manage. It is in development, and it is not for sale yet.

A woman sitting on the edge of a bed at dawn, one hand on her lower back

Coming soon

Most cannabinoids
never arrive.

Oral and oil formats leave much of a cannabinoid unused, and some cannabinoids barely show up in those systems at all. That is the problem this system is being designed to solve.

We have not published the mechanism, the device, or a target tissue. When the work is ready, those details belong in a specification that partners can evaluate, not in a paragraph here.

Ordinary systems

Where ordinary
formats stop.

The three pale lines are ordinary oral, oil and topical formats, and the dots are what they lose on the way to the wall. The ink line is what this system is being built to do. Read it as a sketch of intent rather than a map of tissue.

  1. 01

    Unavailable

    The cannabinoid is in the formula, but too little of it reaches the place it is needed.

  2. 02

    The miss

    Oral and oil formats often stop well short of that place.

  3. 03

    Available

    This system is being built to carry the cannabinoid further, by a route we will describe once it is finished.

A formula can only be judged once the cannabinoid actually arrives.

That is the reason this project exists. In the meantime, the isolates are what we sell.

What we can tell you now.

  • It is a Peregrine delivery system, and it is still in development.
  • It is designed to reach places ordinary formats do not, so that cannabinoids with poor availability become usable in partner programs.
  • Until it ships, the isolates are what you can buy from us.

What we are holding back.

  • The mechanism, the carrier and the target tissue, until they are written up as a specification.
  • Any description of it as a treatment, a trial or an FDA-evaluated product, because it is none of those.
  • A release date. It ships when it is ready and not before.

Ordinary formats versus this system

Ordinary delivery versus the unpublished Peregrine system
Ordinary oral / oilThis system
Where it stopsOften short of the targetDesigned to carry the cannabinoid further
Unavailable cannabinoidsOften stay unavailableThe problem it is built to solve
MechanismWell describedNot yet published
What you can buy todayThe isolates we sellNothing yet; in development
Therapy claimNone from PeregrineNone from Peregrine

For partners

If you already have a product/program.

If the cannabinoid is not reaching where your program needs it, write to us. There is no sample to send yet, but we will tell you plainly whether a conversation makes sense at this stage.

Status
In development
Mechanism
Not yet published
Buy today
Named isolates, 5 g–100 kg
Sleepz
A separate project: a night formula
Meliora
A separate project: cosmetics
This system
Not for sale yet

Where this sits

  1. 01 · Now

    The miss

    Ordinary formats often fail to carry the cannabinoid where it is needed.

  2. 02 · Now

    Build

    We are building it now. The mechanism will be published as a specification, not as marketing copy.

  3. 03 · Not yet

    Specify

    A written specification, a sample and a device photograph will follow once the design is settled.

  4. 04 · Not yet

    Release

    There is no cart for it yet. Until then, the isolates are what we sell.

Partner conversation

Tell us about your program and where you are. We still need the destination jurisdiction, and this is a conversation rather than a sample request.

Requesting Delivery system — partner conversation · select a mass · destination required

Destination *
Your details
Documents

There’s no cart. A person reads your request and replies within one business day.

Also in development

Developments

We will write when there is something to say.

Work email only. This list is separate from the isolate lot notes. Stop mail.

Questions

What is this, exactly?

A delivery system we are still building. The goal is to get cannabinoids to the places ordinary oral and oil formats tend not to reach. We have not published how it works yet, and we would rather do that in a specification than on a web page.

Does this treat pain or disease?

No. Peregrine sells ingredients. This page describes an unfinished piece of engineering, and we make no medical claims for it.

Can I buy it?

Not yet. The isolates are what you can buy from us today; Sleepz and Meliora each have their own page. This system stays in development until we announce otherwise.

Is this Sleepz?

No. Sleepz is a timed-release night formula. This is a separate delivery system, and it is still being built.

Why not name the mechanism?

Because it is unfinished. Describing a mechanism on a marketing page tends to read as a promise, and we would rather hand partners a document they can evaluate.

Who is this for?

Formulators and partners who already run a program and are finding that the molecule is not reaching where they need it. It is not a consumer product.

Can I get a sample of the delivery system?

No, there is no sample yet. Write to us as a partner and we will tell you honestly whether a conversation is possible at this stage. If you need the molecule itself now, the isolates are available.